PathwayReady EGFR Signaling Inhibitor Panel

SKU
P-2381
  • Formula:See under the individual product
  • Appearance:Lyophilized Solids
  • Purity:95% by HPLC
Product Name Qty
PathwayReady™ EGFR Signaling Inhibitor Panel
14 inhibitors
$1,247.29

A convenient set consisting of fourteen inhibitors useful for the study of EGFR signaling pathway. The fouteen inhibitors are: 5 mg of AG 490 (Cat. No. 1570-5), 1 mg of Akt Inhibitor, Isozyme-Selective (Cat. No. 1708-1), 5 mg of Canertinib (Cat. No. 1617-5), 5 mg of Gefitinib (Cat. No. 1589-5), 25 mg of Lapatinib Ditosylate (Cat. No. 1624-25), 5 mg of LY 294002 (Cat. No. 1667-5), 5 mg of PD 98059 (Cat. No. 1666-5), 1 mg of PP2 (Cat. No. 1767-1), 1 mg of Rapamycin (Cat. No. 1568-1), 1 mg of SB 203580 (Cat. No. 1712-1), 25 mg of Sorafenib (Cat. No. 1594-25), 5 mg of SP 600125 (Cat. No. 1669-5), 5 mg of Stat3 Inhibitor, S3I-201 (Cat. No. 1775-5), and 1 mg of ZM 336372 (Cat. No. 1789-1).

More Information
Alternate Name/Synonyms
EGFR Signaling Inhibitor Panel, PathwayReady
SKU
P-2381
Chemical Name
EGFR Signaling Inhibitor Panel, PathwayReady™
Chemical Formula
See under the individual product
Appearance
Lyophilized Solids
Purity
95% by HPLC
Solubility
See under the individual product
Storage Temp
-20°C
THERAPEUTIC AREA
Not Available
USE
Not Available
MDL NUMBER
Not Available
CHEMACX
Not Applicable
INCHI
Not Applicable
SMILES
Not Applicable
Peptide sequence
Not Applicable
RTECS
Not Applicable
UN #'S
Not Applicable
PACKING GROUP
Not Applicable
HAZARD CLASS
Not Applicable
Handling
Protect from air, light and moisture
Handling Protect from air, light and moisture
UN #'S Not Applicable
Packing Group Not Applicable
To Top